DIA 2023: Courtney Granville Discusses Issues Impacting Broader Supply Chains

The investment not only moves along the company’s efforts in advancing clinical studies, but also opens up 700 new jobs for the Greater Toronto area.

Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.

The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.

Rob Sobie outlines the importance of supply chain transparency for the benefit of patients.

A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today.

Pharma Commerce was on the road extensively throughout 2024, and plenty of insight was gathered along the way.